Login
Need to Register?   Forgot Password?
You need to upgrade your Flash Player to view this content.



What's New?
  • New Slides on ARBITER 6—HALTS, data from the AHA 2010 Heart Disease and Stroke Statistics, and more!
    Visit the slide library today to view slides featuring data from ARBITER 6—HALTS, the AHA 2010 Heart Disease and Stroke Statistics, and more, and create your own customized presentations!
  • Updates to the Current Literature Library
    Easily searchable by author or keyword, our current literature library will help you to stay up-to-date with the latest clinical information!
  • Rosuvastatin Receives New Indication
    The FDA has approved a new indication for the cholesterol-lowering medication, rosuvastatin (Crestor). The agent is now indicated for the primary prevention of CVD to reduce the risk of stroke, heart attack, and arterial revascularization procedures among individuals who have no clinically evident heart disease but are at increased risk due to risk factors, including age, elevated CRP, and presence of at least one additional CV risk factor.
  • FDA Issues Warning for Simvastatin
    The FDA has issued a warning for simvastatin (Zocor®), the cholesterol-lowering medication. This warning pertains to the 80-mg dose of simvastatin with regard to potential for increased risk of muscle injury. For more information, click here.
  • Slides of the Month
     
    RECORD: Time to Primary Endpoint
    The Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemi...
    RECORD: Bone Fracture Rates in Upper and Distal Lower Limbs
    The Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemi...
    RECORD: Conclusion
    The Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemi...
    Effects of ↑ HDL-C and ↓ LDL-C on First Acute Major Coronary Events: Results
    This post-hoc analysis of subjects enrolled in the Air Force/Texas Coronary Atheroscle...
    Effects of ↑ HDL-C and ↓ LDL-C on First Acute Major Coronary Events: Additional Results at Year 1
    This post-hoc analysis of subjects enrolled in the Air Force/Texas Coronary Atheroscle...
    Fibrates: Effects on Lipid Profiles and CV Events
    Abourbih and colleagues conducted a systematic review of the literature to assess the ...
    Effect of Statins on Atherosclerosis After ACS: Design
    Rodés-Cabau and colleagues conducted this study to assess the effects of ...
    Effect of Statins on Atherosclerosis After ACS: Percent Change in Atheroma Volume
    Rodés-Cabau and colleagues conducted this study to assess the effects of early ...
    Omega-3 Acid Ethyl Esters in Addition to Statin Therapy: Effects on Lipoprotein Particle Concentrations
    Davidson and colleagues assessed the effects of omega-3 acid ethyl esters (OM-3)...
    NHANES: Gender Differences in Prevalence of Myocardial Infarction
    Towfighi and colleagues reviewed data from two National Health and Nutrition Exa...
    NHANES: Gender Differences in Coronary Risk
    Towfighi and colleagues reviewed data from two National Health and Nutrition Examinati...
    Effects of ↑ HDL-C and ↓ LDL-C on First Acute Major Coronary Events: Design
    This post-hoc analysis of subjects enrolled in the Air Force/Texas Coronary Atherosclero...
    ARBITER 6–HALTS: Final Results
    Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6&mdas...
    Use of CAC Score for CHD Prediction: Design
    Polonsky and colleagues conducted an analysis of subjects enrolled in the Multi-Ethnic Study o...
    Use of CAC Score for CHD Prediction: Results
    Polonsky and colleagues conducted an analysis of subjects enrolled in the Multi-Ethnic Study o...
    In the News

    No articles are available at this time

    Copyright 2009 Medical News Today